Obesity and cryptorchidism across development: an integrated endocrine and metabolic life course framework
-
By
-
Dewei Zhang
-
Qiurong Li
-
Zhao Yang
-
Rentao Nong
-
Chenghao Zhanghuang
-
Bing Yan
-
July 3, 2026
-
Clinical Scorecard: The Relationship Between Obesity and Cryptorchidism Throughout Development: A Comprehensive Endocrine and Metabolic Perspective
At a Glance
| Category | Detail |
|---|
| Condition | Cryptorchidism (undescended testis) |
| Key Mechanisms | Endocrine and metabolic disruptions affecting testicular descent and maturation. |
| Target Population | Male infants and children, particularly those with obesity. |
| Care Setting | Endocrinology and urology clinics. |
Key Highlights
- Obesity alters central HPG-axis regulation and peripheral Leydig cell function.
- Maternal metabolic disorders and EDCs impact androgen signaling during testicular descent.
- Longitudinal endocrine and metabolic surveillance may benefit boys with cryptorchidism.
- Life-course evaluation may improve risk stratification and reproductive outcomes.
- Collaboration between endocrine and urologic specialties is essential for management.
Guideline-Based Recommendations
Diagnosis
- Consider the impact of maternal obesity and metabolic disorders on cryptorchidism risk.
Management
- Integrate metabolic context into the management of cryptorchidism.
Monitoring & Follow-up
- Implement longitudinal endocrine evaluations from minipuberty to puberty.
Risks
- Monitor for reduced fertility potential and increased testicular cancer risk in cryptorchidism.
Patient & Prescribing Data
Male infants and children with cryptorchidism and obesity.
Focus on endocrine and metabolic factors influencing testicular descent.
Clinical Best Practices
- Collaborate closely between endocrine and urologic specialties.
- Evaluate endocrine function in the context of obesity and cryptorchidism.
Related Resources & Content
